1

Flagship event for Mass Life Science Innovation to address question of creativity, June 3, 2014, in Boston

Image  for Life Science Innovation Day 2014

Image for Life Science Innovation Day 2014

On Tuesday, June 3, the Massachusetts Life Science Center (MLSC) will host  its 7th Mass Life Sciences Innovation  Day at the Harvard Club on Commonwealth Avenue, in Boston. Billed on its Website as “the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts,” Mass Life Science Innovation Day is  “a high-energy, hands-on event” at which scientific leaders and business experts mingle with scientists, post-docs, professors, entrepreneurs, innovators, and venture capitalists.  

“This is one of the best opportunities to hear about trends affecting life sciences start-ups and to learn about new technologies that are ready for commercialization, ”  according to Abigail Barrow, Director of the Massachusetts Technology Transfer Center and the conference chair,  

A central question to be addressed at the event involves creativity, according to Barrow. That is, can researchers still be creative with the organizational and financial demands that are placed on research environments?  Do corporations and academics still have the courage to allow their teams to be really creative? If you want to do interesting and exciting science can you still get the funding? How does business and finance leadership view creativity?

“Our speakers and panelists will discuss the current battle to create innovation friendly environments and its impact on entrepreneurs and young researchers finding jobs.”

The morning session will feature a keynote address by Mark Levin, who will speak about how Third Rock, the  venture capital firm he founded,  invests in new companies.

 Brock Reeve, Director of the Harvard Stem Cell Institute, will be the luncheon speaker.
Morning and afternoon breakout sessions featuring more than 40 speakers will cover scientific topics such as indication selection, experiment design and managing research programs as well as entrepreneurial topics including  “how to join the venture capital club,”  how to pitch your new idea, and “where to find money to fund your start-up.”

Some 30 early-stage companies and major research institutions will present posters and compete for prizes to be awarded at the close of the day by State Senator Karen Spilka.  The award-winners will be chosen by 20 Life Science CEOS and biotech leaders who will also attend a closing reception. The reception will include an Innovators Marketplace offering resources needed to commercialize an invention.

 More information on the program and registration is available on  the MLSC website at  –http://www.mattcenter.org/malsi-day-2014/home.html .

Here’s a link to the agenda and a complete list of speakers.
Conference fees range from $60 for students  to $550 for two marketplace exhibitors.

Massachusetts Life Sciences Innovation Day was  developed by the Massachusetts Life Sciences Start-up Initiative (MALSI)–a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI’s mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies.  MALSI partners include: Massachusetts Technology Transfer Center, MassBio, Mass Medical Angels, TiE Boston, and several major universities and research hospitals.

–Anita M. Harris
Anita Harris is an author, photographer  and communications consultant based ib Cambridge, MA. 

New Cambridge Observer is a publication of the Harris Communications Group, an award-winning PR and marketing firm based in Cambridge, MA. 




As Dems Vie for Markey’s Congressional Seat, Personality Is Key

With so many excellent liberal candidates running in the special election primary  for former Congressman Edward Markey’s old seat, I was having trouble deciding whom to vote for. So I decided to attend an event held last Sunday at  Temple Emunah, in Lexington, at which Photo: Congressional candidates for markey seat at temple emunuel lexington ma.2013-09-29_18-16-07_390, seven Democratic candidates expressed their views on gun control, the economy, gay marriage, immigration reform, the Middle East, and the general state of affairs–each in 60 seconds.

The Republican candidates were invited, according to the moderator, but apparently were all attending another event.

The speakers included, from left to right in the photo, left: State Senator William Brownsberger, State Senator Katherine Clark, Middlesex County Sheriff Peter Koutoujian, Martin Long, Paul John Maisano, State Representative Carl Sciortino, and State Senator Karen Spilka.

I was impressed with all of the candidates. While they agreed on nearly all counts–on nearly all issues– there were, of course,  differences in their approaches and personalities.

Brownsberger, of Belmont, seeked rather a proper Bostonian, smart and well-spoken. He emphasized what he called his record of “doing what’s right when it’s difficult”–and that, in light of the current circus (my term) that is Congress…”we need adults in DC.”

Clark, of Melrose,  seemed to be courting the women’s vote–with an emphasis on the importance of  family and community.

Koutoujian, of Waltham, tall and quickwitted, said that as an Armenian whose ancestors experienced genocide,  he  identifies with the Jewish people and strongly supports civil rights, homeland security, justice,   women’s rights,  the Affordable Care Act and an end to gun violence.

Long, with a technology background–described himself as an “agent of change, of new ideas” who believes in “truth in advertising” with regard to special interest groups.  He also supports a return of War Powers to Congress, and a modest capital gains tax  (approximately 2%) to help fund Social Security. (Between us–and his campaign manager– he spoke a bit too quickly to be easily understood).

Maisano, of Stoneham, who speaks with a strong Boston “brogue,” emphasized his  business background. He was the only candidate to say he supports individuals’ rights to own guns, but agreed that strong background checks are needed before purchase.

Sciortina, the youngest of the group, of Somerville is well spoken; in addition to his support of the overall liberal agenda, he focused on his ties to the gay/lesbian/bisexual and transsexual communities and his opposition to the potential use of force in the Middle East.

Spilka, a former labor attorney who is now the state senate’s majority whip and very articulate, characterized herself as believing strongly in social and economic justice.

As mentioned, I was impressed with each of the candidates–and believe that any of them would do a good job of representing my views and those of  the constituents of the broad-ranging Fifth Congressional district. (The district  includes parts of ultra liberal Cambridge and 24 towns stretching from Winthrop and Revere on the Massachusetts Bay to the Metro West communities of Framingham and Ashland.

I never thought I’d say this–(and I’m not saying who has my vote)–but with so many similarities in the candidates’ platforms I’m going to vote based on personality and likeability. That is–I’ll vote for the candidate I think has the best chance of convincing the bozos in DC find some common ground.

The special primary will be held on Tuesday Oct. 15.

Note to the candidates and their supporters–Please feel free to comment if you feel I’ve misstated views or emphases–the presentations were very quick and I was writing very fast. 

–Anita M. Harris

Sunday, September 29, 2013
6:00 p.m.-7:30 p.m.
Temple Emunah, 9 Piper Road, LexingtonPhoto: Congressional candidates for markey seat at temple emunuel lexington ma.2013-09-29_18-16-07_390




Massachusetts to collaborate with innovation regions in Medicon Valley, Skandinavia, and Catalonia, in Spain

Governor Deval Patrick and Medicon Valley Officials after signing collaboration agreement at 2012 Bio International Convention on 6/20/12. Photo by Anita Harris, Harris Communications Group.

“It’s not about what we can give you or take; it’s about how we can share.” So said Massachusetts Governor Deval Patrick before signing a collaboration agreement with officials from Medicon Valley MOU –located in the Capital Region of Denmark, Region Zealand in Denmark and Region Skåne in Sweden. The  agreement was one of two  partnerships signed today between Massachusetts and European regions. The second was with Catalonia, Spain.  Both  agreements were signed at the BIO International Convention.

“Our innovation economy is thriving here in Massachusetts and establishing and encouraging international partnerships is an important part of our future growth,” Governor Patrick said. “Catalonia and Medicon Valley are important regions in Europe’s innovation sector, and these partnerships will allow us to move forward on our mutual goals in this part of the global economy.”

The Medicon Valley memo of understanding (MOU) was signed by Governor Patrick and officials from the Capital Region of Denmark, Region Zealand in Denmark and Region Skåne in Sweden.

The agreement focuses on enhancing research partnerships in life sciences by an exchange of researchers and students; identifying special projects, partnerships or collaborations that can lead to new or enhanced research opportunities; and establishing a framework to be used in joint projects that could be financed by the European Union or National Institute of Health to develop new products and processes that can be used in the global market, according to a press release furnished by the governor’s office.

Medicon Valley is a bi-national region composed of the island of Zealand in eastern Denmark and the Skåne region of southern Sweden. It is home to over 200 companies in biotech, med-tech, and pharmaceuticals with over 350 additional companies in those fields having affiliate or branch offices in the region. These industries employ 40,000 people.

The MOU with Catalonia, Spain was signed by Governor Patrick and the President of Catalonia, Spain Artur Mas I Gavarro, with U.S. Ambassador to Spain Alan Solomont present for the signing. The Patrick-Murray Administration has partnered with the Catalan Government to put real collaboration into a renewed agreement on the 20th anniversary of Lieutenant Governor Paul Cellucci signing a Declaration of Intent of Cooperation in 1992 between Massachusetts and Catalonia, according to the release.

The agreement facilitates collaboration in the following areas:

a)         Bilateral cooperation in research, and technological and industrial innovation;

b)         Business cooperation and economic development in key productive sectors, especially in life sciences, renewable energy, information technology, advanced manufacturing and infrastructure, and;

c)         Academic cooperation.

Catalonia has pursued a policy similar to Governor Patrick’s of investing in the innovation economy. Areas of convergence include the life sciences, mobile devices, clean energy technology, and advanced infrastructure. In 2011, Spain was Massachusetts’ 21st largest export partner, with Massachusetts exporting approximately $326.99 million worth of goods and services.

The BIO International Convention provides Governor Patrick, Lieutenant Governor Timothy Murray, state and industry leaders with an opportunity to showcase Massachusetts as a global leader in the life sciences industry, and the preeminent place for life sciences companies to invest in and expand. On Tuesday, Governor Patrick announced the first round of grants awarded under the Massachusetts-Israel Innovation Partnership (MIIP). MIIP is a formal collaboration between the State of Israel and the Commonwealth of Massachusetts to encourage and support innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors. A total of at least $1.3 million is being awarded to four research & development (R&D) collaborations between Massachusetts and Israeli companies that have been jointly approved by the funding agencies on both sides. The total budget of the awarded projects is estimated at approximately $3 million. The Massachusetts awardees are located in Natick, Needham, North Billerica and Wilbraham.

Earlier on Wednesday, the Governor joined seven global biopharmaceutical companies to announce the formation of the Massachusetts Neuroscience Consortium. Participating companies include Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion Pharmaceuticals Inc. The Consortium will fund pre-clinical neuroscience at Massachusetts academic and research institutions.

Governor Patrick’s ten-year, $1 billion life sciences investment package has strengthened the state’s global leadership in the life sciences. The initiative melds all of the state’s key resources in order to spur research, investment, innovation and commercialization. Now the life sciences industry in Massachusetts is thriving, with more than 52 percent job growth in the biopharma sector since 2001 and more than 80,000 employees working in the life sciences.

 

–Anita M. Harris
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning  public relations and marketing communications agency located in Cambridge, MA.

###

 

 




Downturn + changing VC industry = funding challenges for startups

For entrepreneurs seeking venture capital funding, there’s good news—and there’s bad news. The good news is that  it’s easier now than at any time in the last ten years to get relatively small amounts of seed money. The bad news is that it’s harder to obtain “A Round” or additional series funding after that.

That was the consensus of  three Boston area venture capitalists who spoke at the Cambridge Innovation Center on  Wednesday, May 2.  Moderator Ben Hron of  law firm McCarter -English, which sponsored the event, asked the VCs  how the 2008 economic downturn  has impacted the VC industry;  where things stand now,  and what they foresee for the future.

Impact of the recession
A changing industry
Jo Tango, founder and partner of Kepha Partners, which invests in early stage companies, said that for many VC firms, this is a period of innovation. “We call it VC 2.0,”  he quipped to the audience of  entrepreneurs.  The VC industry, which started in about 1980, used to be dominated by approximately 20 major firms; today, there are more smaller, more specialized VC firms, he said.

David Beisel, co-founder and partner of  NextView Ventures, a dedicated seed-stage venture capital firm focused on Internet startups, said that the downturn has “facilitated a  maturation process,” which he likened to what happened in the beer industry in the 1990s.

That is, “You had to be either one of the biggest, like Anheuser-Busch—or a microbrewery.” Mid-size companies like Genesee fell by the wayside.

Likewise,  today,  he said, “VC firms are no longer trying to be all things to all entrepreneurs; they’re taking a dedicated approach.  Recently, four or five firms raised more than $1B but mid-sized firms are struggling.”

CA Webb, Executive Director of the New England Venture Capital Association, said that considering this a time of “introspection and innovation” is “optimistic…The reality is that the industry is taking a hard look at itself. Some say that the ‘sky is falling,’ because there’s less money being invested; this means that some firms will shut down. Those that succeed will need to articulate clearly just what they are willing to offer and to whom.”

Tango pointed out that “Innovation [in the VC industry] creates a challenge for entrepreneurs because VC firms are “all over the map,” and “it’s difficult to know which one is right for [a particular startup]. It’s easier now to get seed money–but terms are often more difficult to distinguish.”

 

Current trends
In asking the panelists for their views on the current venture funding situation, Hron shared Q1 2012 statistics showing  a large number of deals but a drop in total funding compared with previous quarters– in indicating fewer “megadeals.”  “Should entrepreneurs should be optimistic because of the number of deals or pessimistic about the size of the deals?” he asked.

Fewer large deals
Tango responded that one reason for the decline in large deals has to do with the number of deals VCs have previously closed.  In the current economic climate, he explained, it’s difficult raise a stream of money. In a recent study of five VC Web sites, his firm found that many VCs are already sitting on the boards of 10-17 companies in which they have invested. “If you’re fundraising…if you’re already on 15 boards, you need to spend your time fund raising,” not sitting on additional boards.

Smaller investments
Beisel described what he called a longer term trend:  in some sectors, especially digital media, companies don’t need to raise as much money for initial funding as in other sectors–so at earlier stages, the venture community is reacting by not writing $5M checks but rather $1M or .5 M.

In Webb’s view, “seeding is now like the old Series A funding: there is a lot of seed money to go around but Series A is now looking like the old series C “(IE–difficult to come by).

Follow-on funding can be problematic.
Tango agreed –describing a firm that backed 20 companies with seed money but told him it will provide only 2 % of those with Series A funding.  He added that the situation is even more complicated because even at the “seed stage,”different VCs require different terms.

In fact, he recommended, “Ninety per cent of startups should be bootstrapped (funded by self, friends and family) because other investors expect that they will get their money out within a few years. “With VC funding, you’re becoming a fiduciary…taking on ‘credit card debt’ that you will need to pay back.”

In Beisel’s view, before taking any money from VCs, an entrepreneur needs to know how outsiders view the firm, the reputation of the VC firm, which partner will be best for the company, and whether the firm usually adds to series funding or “will you be one of the 98% that get dropped?”

Health care vs. other  investment
Citing a decline in financing for health care ventures in Massachusetts compared with increased financing for Internet and mobile technology, Hron asked if investors are seeking short-term gains as instead of  taking the long view required for biotechnology and pharma payback.

Webb responded that one reason for the slowdown in health care company funding is that the US Food and Drug Administration is taking longer to approve products so the horizons for investors are longer. As a result, investors are shifting toward healthcare technology, “big data” and products that will bring a quicker return.

In Beisel’s view, “Over the last ten years the returns for health care investment have not been that great; health care is now even more challenging. But VCs won’t shift to other spaces; the money just won’t get raised.”

Long -term trends
According to Hron, the data suggest a rise in VC investing in Washington State, Texas, and Illinois. “Are we seeing the rise of a national VC community or is this a blip?” he asked. “And will VC investors look at companies nationwide?”

Tango and Beisel agreed that large investors are looking at companies nationally and internationally–especially in the Internet space.

They also agreed that it’s unlikely that VCs will spring up in Kansas or in “third-tier American cities,” as Beisel; put it.  In Tango’s view, “they will still be centered in Boston, NY and California.”  Beisel pointed out that that VC firms are on the rise in nations like Argentina and Eastern Europe.  According to Webb, “Capital clusters around academic institutions: You won’t see much density elsewhere.”

Crowd sourcing
Regarding the  recent passage of legislation allowing corporate fundraising through crowd sourcing, panelists expressed concerns about possibilities for fraud and entry of organized crime; and also  that unsophisticated investors might not know that seasoned professionals expect to lose money on most  investments—in hopes that a few will have big payoffs.

Asked by Hron if VCs will look askance at companies raising initial funding through crowd sourcing, Beisel said  that it’s fine to get seed money wherever you can but a “real company” will need institutional investors in order to grow large.

In Tango’s view, “Your source of funding depends on what you want to accomplish: Do you just want to get money…or are you looking for series of VC rounds, advice and support?”

 

PANELIST BIOs

David Beisel – David is Co-Founder and Partner of NextView Ventures, a dedicated seed-stage venture capital firm focused on investments in internet startups.  Previously he was an investor at both Venrock and Masthead Venture Partners, where he served on the boards of BlogHer and Gazelle.  Prior to joining Masthead, he co-founded Sombasa Media, an e-mail marketing company which was successfully acquired by About.com and subsequently became a division of Primedia (NYSE: PRM), where he served as Vice President of Marketing.  He is also the founder of the Web Innovators Group, a quarterly entrepreneur-focused event which attracts nearly a thousand attendees.  David blogs atwww.GenuineVC.com.

Jo Tango – Jo is Founder and Partner of Kepha Partners, an early-stage venture capital firm.   Previously, Jo spent was a General Partner at Highland Capital Partners, where he worked for nearly nine year, and before that he spent five years with Bain & Company.  Jo has invested in the e-commerce, search engine, Internet ad network, wireless, supply chain software, storage, database, security, on-line payments and data center virtualization spaces.  He has been a founding or first institutional investor in Azuki Systems, Bit9, ExaGrid, StreamBase Systems, Vertica Systems (acquired by Hewlett-Packard), Virtual Iron (acquired by Oracle) and VoltDB, getting involved nearly always at the company inception phase. Other investments include Ask Jeeves (Nasdaq: ASKJ), Digital Market (acquired by Agile Software), and NextCard (Nasdaq: NXCD).

C.A. Webb – C.A. became the Executive Director of the New England Venture Capital Association in January 2012.  Members of the NEVCA include more than 700 venture capital professionals from over 100 firms that collectively manage more than $50 billion in capital.  C.A. has spent her career in entrepreneurial roles with mission driven, early stage and high growth organizations. Her work has focused on breakthrough business models in a diverse array of industries including retail and packaged goods (Whole Foods Market), consumer internet technology (Care.com), sustainability (Preserve Products), historic preservation (Trinity Boston Foundation), public education (Boston Collegiate Charter School), and publishing (Fast Company magazine




Artists El Anatsui and Chihuli Bring Glass, Wood, Color, Imagination to Life

After a week of torrential rains,  my friend E and I  felt a huge need for light and color–so took in  two excellent retrospective art exhibits: Dale Chihuli’s  Through the Looking Glass at the Boston Museum of Fine Arts and   El Anatsui‘s When I Last Wrote to You about Africa at  Wellesley College’s Davis Museum, in Wellesley, MA.

Through the Looking Glass is a 40-year retrospective of the Washington State artist’s blown glass sculptures–such as a boat containing thousands of  glass flowers, fantastical forests,  sculptures based on South American basketry–which took  us out of our doldrums and got our imaginations flowing and reminded us that we can each create worlds of our own.

El Anatsui, Plot A Plan III, 2007. Aluminum and copper wire, 73 x 97 in. Photo courtesy: Jack Shainman Gallery. In When I Last Wrote to You about Africa ,  the  West African artist El Anatsui  transformed mundane materials into forms and objects that were beautiful and real.

Surveying nearly five decades of the West African artist’s internationally renowned career, the exhibit featured some sixty works in wood, metal ceramic, painting, print and drawing.  E and I especially loved the gorgeous tapestry created from used wine-bottle caps and labels; wooden sculpture made from open boxes meant to remind viewers of the opening of market stalls and paintings of African colors, shapes. More difficult and disturbing was  a stone-carved head–with traditional face but open in back to reveal not much in the brain.

An additional highlight was an exhibit of fashions designed by Wellesley students–meant to interpret the  show.  I particularly liked one showing a long, flowing fancy dress which, on closer glance, turned made of a black garbage bag, with collar and ruffle resembling feathers–but made from cut up magazines–all commenting on the ephemeral nature, I believe, of show business careers.    E was partial to a dress with a bodice composed of typewriter keys…reflecting El Anatsu’si use of everyday objects in creating new ones.

Apologies for waiting so long to see/write about this one–(it closed on June 26) but E says the ICA has acquired one of the works; that will definitely be worth seeing, there.

Chihuly/ Through the Looking Glass will be at the Museum of Fine Arts, Boston, through August 7, 2011.

Anita M. Harris

Anita M. Harris is a journalist, photographer and President of the Harris Communications Group of Cambridge, MA.




Harvard Square farm stand worth a visit

 On a recent Saturday morning, after coffee at the Charles, I was struck by the beautifully displayed fruit and vegetables in one of the farmers market stalls on Mt. Auburn Street.

I asked the proprietor if it would be OK to take some photos,  then, like every other visitor to the stand, asked him what on earth those shiny pale white, pink and reddish berries were. P1010088 One customer guessed elderberries, but the proprietor, Frank Buso, said they’re  currents ($4 a pound).   Buso said  he grows them–and everything else in the stand–at his farm in Lincoln– located on Battle Road in the Minuteman National Park.  [Click here for Minute Centennial Celebration events]. P1010072

Busa’s is one of a handful of  farms leased at very low cost (approximately$25 an acre) from the Park itself. The goal,according to  Park spokesman Lew Sedaris,  is to help preserve the scene of the 1775 Revolutionary War battle fought in Lexington, Lincoln and Concord –much as other national parks preserve their natural settings.

 Busa started his Lincoln  farm  two  years ago–after his family sold its farm, also called Busa’s, in Lexington. Now, Busa sells  fruits and vegetables at farmers markets in  Bedford, Lexingtonn Arlington and Cambridge.      

Compared with Haymarket–where you take a chanceP1010089 on freshness– Busa’s and the other Harvard Square stands are a bit pricey–$4 for a pint of blueberries, $2 for a head of  lettuce, a bunch of scallions or basil.  Hot peppers are 5 for a dollar, and tomatoes go for $3.00 a pound.  But everything at Busa’s looks delicious. Although I’d already done my  shopping for the week,   I found the stand worth visiting for both the conversation and the view.

                                                                   Photos and text c. Anita M. Harris, 2009.

–Anita M. Harris

New Cambridge Observer is a publication of the Harris Communications Group of Cambridge, MA. We also publish Harriscomblog.




Kimball's Ice Cream at Bates Farm, Carlisle: Review

I couldn’t understand why the editor of the Lincoln (MA) Review,  would ask members of my writers group for pieces on our favorite ice cream shops…Doesn’t everyone already know that Kimball’s at Bate’s Farm  (343 Bedford Rd, Route 225), in Carlisle  is the best place in the world to go for ice cream?

I live in Cambridge—walking distance from Steve’s,  Herrells, Lizzie’s, Toscanini’s, Emack and Boglio, Berry Line and the now defunct Bailey’s, in Harvard Square.  

But none of those can compete with Kimball’s/Bates Farm for ambience, flavors, serving size or price.

 At Bates, it’s  fun to see the kids and the farm animals, teenagers on dates –apologies for the non-sequitor–but last Spring, my friend Lisa and I were amused to watch kids watching sheep who appeared to be on dates)– and to join folks and families sitting outside at outdoor picnic tables.

But, mostly, the ice cream itself is, simply, great.  More flavors than I can list here. I’ve forsaken coffee heath bar crunch for a new best friend :  mocha almond assault—but for the ostensibly health conscious, there are  sherbet, sorbet or  frozen yogurts like peanut butter fudge swirl and black raspberry chocolate chip.

The portions are huge (another reviewer says the “baby” cone is actually the size of a baby)—and, while Kimball’s/Bates prices gone up considerably in the last few years,  compared with Cambridge,  the prices are right ( $3.25 for baby, $3.60 for small, $3.95 for large).

 I can’t vouch for the other Kimballs –there’s one on Route 14 in Jaffery, NH, and another  at 400 Littleton Rd, in Westford (the latter has a seafood restaurant, miniature golf, a driving range and a bumper boat pond)—but all serve the same delicious, cold, rich, creamy stuff.  

Best of all, for me, the Kimball’s experience is wonderfully dietetic. With Bates Farm, the closest, almost 20 miles from my home, I can’t get there often. And because what they offer is so good, I no longer bother going anyplace else.  

——–Anita Harris

New Cambridge Observer is a publication of the Harris Communications Group of Cambridge, MA.   HarrisCom also publishes HarriscomBlog, at http://blog.harriscom.com. A version of this writeup appeared in the Lincoln Review.




Mass. Life Sciences Center sees 8-fold return in year 1

Over lunch at the Cambridge Innovation Center on Wednesday,   Mass Life Sciences Center (MLSC) President and CEO Susan Bannister told a gathering of some 100 life science afficionados that the first year of Gov. Deval Patrick’s Life Science Initiatiative has been a success. 

The MLSC, charged with distributing some $1B over a ten year period,  invested  $48.5 M in public dollars this year–its first full year of operation.  The funds, in turn, have attracted nearly $359M in matching investments from companies, foundations, government, institutes and other private investors–an eight-fold return.  

“There’s still capital out there and life science is a good place to put your money,” Bannister said.  “By putting state money into the pot, we have ‘de-risked’ investment that the state would have had to find elsewhere”.

 The funded projects–in biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics–could create some 950 jobs in the near term, Bannister said.

By adding employment opportunities,  Massachusetts’  investments and incentives could help to absorb some of the job losses expected in other sectors, according to Bannister.

Frank Reynolds, CEO of InVivo Therapeutics, which is developing stem cell/ polymer technology aimed at halting the effects of traumatic spinal cord injury, said that receiving a $500 thousand loan just as  venture capital possibilities tanked this fall made a tremendous difference in his company’s ability to proceed. ”  It’s a great program,” Reynolds said. (Disclosure:   I work with InVivo).

Bannister cautioned  that in the current economic downturn, tax revenues are “iffy” and it’s not yet clear how much money will be available for the Initiative in 2010.

For more details, please visit  Harriscomblog.wordpress.com.

—Anita Harris

New Cambridge Observer is a publication of the Harris Communications Group of Cambridge, MA.